689 related articles for article (PubMed ID: 27933277)
21. Omega-3 Polyunsaturated Fatty Acids Prevent
Choi JW; Lee J; Lee JH; Park BJ; Lee EJ; Shin S; Cha GH; Lee YH; Lim K; Yuk JM
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31500218
[TBL] [Abstract][Full Text] [Related]
22. Effects of Aloe vera and Eucalyptus methanolic extracts on experimental toxoplasmosis in vitro and in vivo.
Mirzaalizadeh B; Sharif M; Daryani A; Ebrahimzadeh MA; Zargari M; Sarvi S; Mehrzadi S; Rahimi MT; Mirabediny Z; Golpour M; Montazeri M
Exp Parasitol; 2018 Sep; 192():6-11. PubMed ID: 30031121
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
24. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
25. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants.
Franco PS; Gois PSG; de Araújo TE; da Silva RJ; de Freitas Barbosa B; de Oliveira Gomes A; Ietta F; Dos Santos LA; Dos Santos MC; Mineo JR; Ferro EAV
J Biomed Sci; 2019 Jan; 26(1):10. PubMed ID: 30665403
[TBL] [Abstract][Full Text] [Related]
26. Effect of the Synadenium carinatum latex lectin (ScLL) on Leishmania (Leishmania) amazonensis infection in murine macrophages.
Afonso-Cardoso SR; Silva CV; Ferreira MS; Souza MA
Exp Parasitol; 2011 May; 128(1):61-7. PubMed ID: 21320493
[TBL] [Abstract][Full Text] [Related]
27. Protection against Paracoccidioides brasiliensis infection conferred by the prophylactic administration of native and recombinant ArtinM.
Coltri KC; Oliveira LL; Ruas LP; Vendruscolo PE; Goldman MH; Panunto-Castelo A; Roque-Barreira MC
Med Mycol; 2010 Sep; 48(6):792-9. PubMed ID: 20392144
[TBL] [Abstract][Full Text] [Related]
28. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
Zimmermann S; Dalpke A; Heeg K
Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
[TBL] [Abstract][Full Text] [Related]
29. Peroxiredoxin 3 promotes IL-12 production from macrophages and partially protects mice against infection with Toxoplasma gondii.
Fereig RM; Nishikawa Y
Parasitol Int; 2016 Dec; 65(6 Pt A):741-748. PubMed ID: 27644889
[TBL] [Abstract][Full Text] [Related]
30. Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis.
Heimesaat MM; Dunay IR; Alutis M; Fischer A; Möhle L; Göbel UB; Kühl AA; Bereswill S
PLoS One; 2014; 9(8):e105120. PubMed ID: 25141224
[TBL] [Abstract][Full Text] [Related]
31. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
32. ArtinM: Purification and Evaluation of Biological Activities.
da Silva TA; Oliveira-Brito PKM; de Oliveira Thomaz SM; Roque-Barreira MC
Methods Mol Biol; 2020; 2132():349-358. PubMed ID: 32306342
[TBL] [Abstract][Full Text] [Related]
33. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
[TBL] [Abstract][Full Text] [Related]
34. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
35. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
[TBL] [Abstract][Full Text] [Related]
36. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
Sina S; Mohammad JM; Reza S; Anita M; Soudabeh E; Hadi M
Eur J Med Res; 2021 Jun; 26(1):65. PubMed ID: 34193287
[TBL] [Abstract][Full Text] [Related]
37. High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency.
Majeed QAH; Alnomasy SF; Shater AF; Alanazi AD
Acta Parasitol; 2024 Jun; 69(2):1201-1211. PubMed ID: 38634986
[TBL] [Abstract][Full Text] [Related]
38. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
39. Anti-parasitic activity of Annona muricata L. leaf ethanolic extract and its fractions against Toxoplasma gondii in vitro and in vivo.
Miranda NC; Araujo ECB; Justino AB; Cariaco Y; Mota CM; Costa-Nascimento LA; Espindola FS; Silva NM
J Ethnopharmacol; 2021 Jun; 273():114019. PubMed ID: 33716084
[TBL] [Abstract][Full Text] [Related]
40. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
English ED; Boyle JP
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
